← Back
Medicus Pharma
MDCX · listed on Nasdaq · worth $3.08 million
$2.48
−13.31% today
No insider bought or sold Medicus Pharma stock on the market in the last year.
No insider trades or company news in this range.
2 reverse splits here, the latest 1-for-50 in Oct 2026. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what MDCX ever actually traded at. The drop is real, but those huge old numbers aren't.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
1.1M shares
73% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
No insider bought or sold Medicus Pharma stock on the market in the last year. The reports below are share awards and other paperwork.
Big investors
People and funds that reported owning 5% or more of Medicus Pharma, newest first.
All reports
Every insider trade and SEC report we hold for Medicus Pharma.
Newest first
No one bought or sold MDCX on the market in these reports. Tick the box above to see the paperwork.
Analysts, earnings and news
Analysts' price target
$4.50 average
4 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
0 of 4 quarters above
Q2 '26−$0.21 a share−$0.05
Q1 '26−$0.30 a share−$0.08
Q4 '25−$0.44 a share−$0.15
Q3 '25−$1.09 a share−$0.71